News
Low blood sugar contributes to eye damage and vision loss in diabetic retinopathy; an experimental drug may help treat the ...
Scientists say they have determined that low blood sugar, or hypoglycemia, may promote a breakdown of the blood-retinal barrier, an important boundary that regulates the flow of nutrients, waste and ...
In a new study led by scientists at the Wilmer Eye Institute, Johns Hopkins Medicine researchers say they have determined ...
New research reveals that hypoglycemia may worsen diabetic retinopathy by breaking down the blood-retinal barrier.
9d
Pharmaceutical Technology on MSNFDA awards RMAT status to 4DMT diabetic macular oedema therapyD Molecular Therapeutics (4DMT) has received the regenerative medicine advanced therapy (RMAT) designation from the FDA for ...
9d
Northamptonshire Telegraph on MSNEye team at KGH shortlisted for national award for new serviceA Kettering General Hospital eye team have been shortlisted for a national diabetes excellence award for the service they ...
Diabetic retinopathy, a severe complication of both ... Some diabetic mice received an injection of 32-134D prior to induced episodes of low blood sugar, and researchers observed lower HIF levels ...
In this Healio Video Perspective from the ARVO meeting, Justis P. Ehlers, MD, shares results from the phase 1 HELIOS study investigating OTX-TKI for the treatment of nonproliferative diabetic ...
15d
MedPage Today on MSNAlternative to Anti-VEGF Shows Safety, Efficacy in Diabetic Macular EdemaA single intravitreal injection of UBX1325 (foselutoclax) was shown to be safe in patients with diabetic macular edema. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results